Boris Nasseri

Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

Daniel J.F.M. Thuijs, A. Pieter Kappetein, Patrick W. Serruys et al. · The Lancet · 2019 · 618 citations · Full text

Percutaneous Coronary Intervention, Controlled Syntax Trial, Endovascular Technique +8

Endothelial Nitric Oxide Synthase Limits Left Ventricular Remodeling After Myocardial Infarction in Mice

Marielle Scherrer‐Crosbie, Roman Ullrich, Kenneth D. Bloch et al. · Circulation · 2001 · 309 citations

Percutaneous transvenous cellular cardiomyoplasty

Craig A. Thompson, Boris Nasseri, Josh Makower et al. · Journal of the American College of Cardiology · 2003 · 188 citations

Cardiomyopathy, Heart Failure, Structural Heart Disease +3

Autologous CD133+ bone marrow cells and bypass grafting for regeneration of ischaemic myocardium: the Cardio133 trial

Boris Nasseri, Wolfram Ebell, Michael Dandel et al. · European Heart Journal · 2014 · 126 citations

Pulsatile Flow in Patients With a Novel Nonpulsatile Implantable Ventricular Assist Device

Evgenij Potapov, Matthias Loebe, Boris Nasseri et al. · Circulation · 2000 · 125 citations